Huntsman (HUN)
(Delayed Data from NYSE)
$22.05 USD
+0.10 (0.46%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $22.06 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.05 USD
+0.10 (0.46%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $22.06 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
Zacks News
Celanese (CE) Up 15% in 6 Months: What's Driving the Stock?
by Zacks Equity Research
Better-than-expected Q2 results and upbeat outlook drives Celanese's (CE) shares.
Is Huntsman (HUN) a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Huntsman (HUN) have what it takes? Let's find out.
Top Ranked Value Stocks to Buy for August 27th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, August 27th:
Air Products (APD) Buys Rotoflow Turboexpander Business
by Zacks Equity Research
Air Products' (APD) latest buyout extends existing capabilities into growing petrochemical, energy and hydrocarbon segments.
Is Huntsman (HUN) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Eastman Chemical (EMN) Raises Prices of Plasticizers
by Zacks Equity Research
Eastman Chemical (EMN) increases Plasticizers prices due to elevated costs of raw materials.
Looking for Value? Why It Might Be Time to Try Huntsman (HUN)
by Zacks Equity Research
Huntsman (HUN) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
CF Industries Up 19% in 3 Months: What's Driving the Stock?
by Anindya Barman
Better-than-expected Q2 results and upbeat nitrogen demand and pricing outlook have contributed to the rally in CF Industries' (CF) shares.
Huntsman (HUN) Opens New Manufacturing Facility in Vietnam
by Zacks Equity Research
The new site will house Huntsman's (HUN) polyurethanes and advanced materials businesses.
Eastman Chemical (EMN) Raises Prices of Acids and Alcohols
by Zacks Equity Research
Eastman Chemical (EMN) hikes acid and alcohol product prices due to higher market demand and elevated operating costs of raw materials.
LyondellBasell Initiates Construction of $2.4B PO/TBA Plant
by Zacks Equity Research
LyondellBasell (LYB) is building the plant to cater to the rising global demand for urethanes.
Mosaic (MOS) Stock Up 46% in a Year: What's Driving It?
by Anindya Barman
Strong earnings outlook, healthy demand and pricing trends for nutrients and upbeat prospects from the Vale Fertilizantes acquisition are driving Mosaic's (MOS) shares.
Methanex (MEOH) Up 26% in 6 Months: What's Behind the Rally?
by Anindya Barman
Strong demand and pricing fundamentals for methanol have contributed to the run up in Methanex's (MEOH) shares.
Harmony Gold's (HMY) Profits Drop, Sales Rise Y/Y in FY18
by Zacks Equity Research
Harmony Gold's (HMY) revenues improve 12% in FY18 owing to higher gold sales. It expects to produce 1.45 million oz of gold in fiscal 2019.
LyondellBasell (LYB) Wraps Up A. Schulman Acquisition
by Zacks Equity Research
The buyout doubles the size of LyondellBasell's (LYB) existing compounding business
Ingevity (NGVT) Up 26% in 3 Months: What's Behind the Rally?
by Anindya Barman
Forecast-topping Q2 results and upbeat outlook have contributed to the run-up in Ingevity's (NGVT) shares.
Cabot (CBT) Up 11% in 3 Months: What's Driving the Stock?
by Anindya Barman
Strong Q3 earnings and upbeat outlook for Reinforcement Materials and Performance Chemicals segments have contributed to the gain in Cabot's (CBT) shares.
Praxair (PX) & Linde Merger Obtains EU Antitrust Approval
by Zacks Equity Research
Praxair (PX) and Linde merger receives EU antitrust regulators' approval, taking a step forward for creation of a leading industrial gas company.
Air Products (APD) Clinches Jiutai Syngas Supply Contract
by Zacks Equity Research
Air Products (APD) to invest $650 million in the project, which is expected start in the fourth quarter of fiscal 2021.
5 Reasons to Add Cleveland-Cliffs Stock to Your Portfolio Now
by Zacks Equity Research
Strong fundamentals and upbeat prospects make Cleveland-Cliffs (CLF) an attractive investment choice.
5 Reasons That Make Celanese (CE) Stock a Solid Choice Now
by Anindya Barman
Strong growth prospects and upbeat outlook make Celanese (CE) an attractive investment option.
Here's Why You Should Hold on to Praxair (PX) Stock for Now
by Zacks Equity Research
Praxair (PX) to gain from growing energy and industrial end markets, strong backlog and new order wins despite concerns in Brazilian economy and a strong U.S. dollar.
Celanese Raises Price of Engineered Materials Polymer Products
by Zacks Equity Research
Celanese (CE) will put the price hike into effect by or after Aug 23.
Why Should You Add ArcelorMittal (MT) to Your Portfolio Now?
by Anindya Barman
Based on its compelling prospects, we believe ArcelorMittal (MT) has plenty of upside potential.
Westlake Chemical Bumps Up Share Buyback, Hikes Dividend
by Zacks Equity Research
Westlake Chemical's (WLK) latest move will make roughly $290 million available for purchase, following the expansion of the share repurchase program.